Promino Nutritional Sciences agreed to settle $373,910 of convertible debenture debt by issuing 5.34 million common shares at $0.07 each. Additionally, the company extended the maturity dates of certain convertible debentures from 2025 to 2027 and lowered the conversion price from $0.30 per unit to $0.07 per share. This move helps Promino manage its debt and potentially improve its financial flexibility as it continues to develop its muscle health nutrition products.
Bluejay Diagnostics completed a private placement raising $8.5 million upfront, with potential additional proceeds of $15.2 million if warrants are fully exercised. The funds will support FDA approval processes, including clinical studies, and genera...
At B2Gold Corp's 2026 Annual General and Special Meeting, shareholders voted on key company matters with 63.06% turnout. All ten nominated directors were re-elected with strong support, and resolutions to appoint PricewaterhouseCoopers LLP as auditor...
Zcash faced a counterfeiting bug scare that caused market pressure and price drops. The Gemini co-founders, Tyler and Cameron Winklevoss, support Zcash's move to use formal verification—a mathematical method to ensure software security—to prevent suc...
Venice Token (VVV) surged 10.36% to $18.29, driven by growing investor interest in decentralized finance (DeFi) platforms where it plays a key role. Its market cap reached $856.45 million, reflecting increased confidence. Meanwhile, other tokens like...
In Q1 2026, professional investors reduced Bitcoin holdings by 17%, mainly hedge funds and brokerages, amid a 22% BTC price drop. Morgan Stanley and Jane Street notably cut exposure, reflecting short-term risk reduction. Meanwhile, banks, governments...
